Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1994 1
1995 1
1998 2
2001 2
2004 2
2006 1
2018 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
A Preliminary Report Requiring Continuation of Research to Confirm Fallopian Tube Adenocarcinoma: A Non-Experimental, Non-Randomized, Cross-Sectional Study.
Ma X, Huang X, Chen C, Ding Y. Ma X, et al. Med Sci Monit. 2018 Jul 30;24:5301-5308. doi: 10.12659/MSM.909661. Med Sci Monit. 2018. PMID: 30059956 Free PMC article.
The purpose of this study was to investigate parameters of different types of magnetic resonance images for women with fallopian tube adenocarcinoma and to compare these parameters with the FIGO grading system to improve the accuracy of diagnosis and prognosi …
The purpose of this study was to investigate parameters of different types of magnetic resonance images for women with fallopian t …
Prognosis of primary fallopian tube adenocarcinoma: report of 25 patients.
Wang PH, Yuan CC, Chao HT, Juang CM, Ng HT. Wang PH, et al. Eur J Gynaecol Oncol. 1998;19(6):571-4. Eur J Gynaecol Oncol. 1998. PMID: 10215444
PURPOSE OF INVESTIGATION: Because of the rarity of primary fallopian tube adenocarcinoma (PFTA), the optimal management has not been well-defined, especially in early-stage disease. ...
PURPOSE OF INVESTIGATION: Because of the rarity of primary fallopian tube adenocarcinoma (PFTA), the optimal management …
Phase II study of a combination of cyclophosphamide, adriamycin and cisplatin in advanced fallopian tube carcinoma. An EORTC gynecological cancer group study. European Organization for Research and Treatment of Cancer.
Wagenaar HC, Pecorelli S, Vergote I, Curran D, Wagener DJ, Kobierska A, Bolis G, Bokkel-Huinink WT, Lacave AJ, Madronal C, Forn M, de Oliveira CF, Mangioni C, Nooij MA, Goupil A, Kerbrat P, Marth CH, Tumolo S, Herben MG, Zanaboni F, Vermorken JB. Wagenaar HC, et al. Eur J Gynaecol Oncol. 2001;22(3):187-93. Eur J Gynaecol Oncol. 2001. PMID: 11501769 Clinical Trial.
RESULTS: Twenty-four eligible patients with histologically-confirmed Fallopian tube adenocarcinoma were entered in the trial. Fourteen patients had FIGO stage III, and ten had stage IV disease. ...CONCLUSION: The present data confirm the therapeutic ac …
RESULTS: Twenty-four eligible patients with histologically-confirmed Fallopian tube adenocarcinoma were entered in the …
Adenocarcinoma of the fallopian tube: report of a case with an unusual pattern of metastasis and response to combination chemotherapy.
Young JA, Kossman CR, Green MR. Young JA, et al. Gynecol Oncol. 1984 Feb;17(2):238-40. doi: 10.1016/0090-8258(84)90082-9. Gynecol Oncol. 1984. PMID: 6546733
A patient with stage I fallopian tube adenocarcinoma had disease recurrence in both lungs shortly after completing adjuvant therapy with intraperitoneal 32P and parenteral cyclophosphamide. She achieved a complete clinical response to cisplatin, Adriam …
A patient with stage I fallopian tube adenocarcinoma had disease recurrence in both lungs shortly after completing adju …
Primary fallopian tube adenocarcinoma in situ associated with adjuvant tamoxifen therapy for breast carcinoma.
Sonnendecker HE, Cooper K, Kalian KN. Sonnendecker HE, et al. Gynecol Oncol. 1994 Mar;52(3):402-7. doi: 10.1006/gyno.1994.1069. Gynecol Oncol. 1994. PMID: 8157199
We report the first case of primary fallopian tube adenocarcinoma in situ in a patient who had received antiestrogen tamoxifen as adjuvant therapy for breast carcinoma. Clinical and in vivo animal model studies, referable to the possible estrogen agoni …
We report the first case of primary fallopian tube adenocarcinoma in situ in a patient who had received antiestrogen ta …
11 results